Cargando...
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...
Guardado en:
| Publicado en: | J Gynecol Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823988/ https://ncbi.nlm.nih.gov/pubmed/29468856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e32 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|